BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
T cell receptor signaling pathway
,
Breast Cancer
,
Hippocampus
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cadherin, N-terminal
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Fetal brain
Tongue superior part with papillae
Ileum mucosa
Pharyngeal mucosa
Stomach pyloric
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Helicobacter pylori gastrointestinal tract infection
Infection due to Fusobacterium
Infection due to Citrobacter
Psoriasis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
famoxadon
homoharringtonine
Agouti Signaling Protein
benz(a)anthracene
pyridaben
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR9-1
HECTD1
BAZ1B
MBD1
SLC4A11
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Apelin and APJ knockdown in pulmonary artery endothelial cells
Early stage breast cancer miRNA expression profiles
Primary plasma cell leukemia and multiple myeloma miRNA expression profiles
Human hepatocellular carcinoma microRNA profiles
Recurrent prostate cancer following radical prostatectomy miRNA profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Cadherin, N-terminal
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-prot…
A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors
Therapeutic Approaches to Malnutrition Enteropathy
PF-06671008 Dose Escalation Study in Advanced Solid Tumors
Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ